UPDATE: Lilly settles pollution suit for $337,500
A complaint filed Wednesday by the U.S. government says Lilly’s plant on South Harding Street is emitting high levels of acetonitrile and methanol, considered hazardous air pollutants by the EPA.
Health Care
Articles
Eli Lilly neuroscience chief resigns
David Bredt, vice president of neuroscience research, has resigned “to pursue other opportunities,” according to Lilly spokeswoman Judy Kay Moore. Bredt had overseen Lilly’s development of various drugs, including molecules in late-stage human testing to treat Alzheimer’s and depression.
Franciscan’s electronic records rollout shows industry growth
Franciscan Alliance will spend more than $100 million over the next two years to install a common electronic medical record system at its 13 hospitals and more than 165 physician practices. It’s a sign of the growth of the health information technology industry in Indiana, which a new BioCrossroads report says generates $200 million a year in sales and is growing at 8 percent annually.
St. Vincent CEO takes on new duties in Wisconsin
St. Vincent Health CEO Vince Caponi will take charge of three hospitals in Wisconsin that are also owned by St. Vincent’s parent organization, Ascension Health. He’ll also keep his current job.
Fort Wayne firm to open health info to patients
With electronic medical record systems proliferating, there’s information galore about patients. But it’s not so easy for patients to get at it. Now Fort Wayne-based NoMoreClipboard has been charged to design ways to fix that problem.
Reform, revenue behind Franciscan expansion
Changes unleashed by health reform are pushing Franciscan St. Francis Health’s expansion into Hamilton County—in addition to the obvious pull of the area’s well-heeled population.
St. Francis plans $23 million Carmel hospital
Franciscan St. Francis Health plans to open a short-stay medical center in Carmel, creating 76 jobs by 2015, the health system announced Monday morning.
Lilly names new head of cancer drug business
Eli Lilly and Co. on Friday named company insider Sue Mahony as president of its cancer drug business.
Lilly takeover provision to be voted on again
The effort to remove an 80-percent approval threshold for takeover bids against the wishes of Lilly’s board is on the agenda of the company’s April 18 annual meeting.
Medicaid expansion could tax community health centers
The president of the Indiana Primary Health Care Association wants to double the number of federally qualified community health centers in Indiana in the next five years.
Repeated price cuts take glow off Endocyte IPO
New investors got in for $6 a share—which is less than the average price paid by prior investors, a regulatory filing reveals.
Health insurers expect hit from reform rule
Major health insurers, including WellPoint, say a provision that requires them to spend a certain percentage of the premiums they collect on care-related costs will eat into earnings this year.
Arcadia reports smaller loss on increased revenue
The Indianapolis-based health care company lost $2.3 million on revenue of $26.2 million in its third fiscal quarter.
Lilly collaboration with outside researchers yields first deal
Eli Lilly and Co.’s PD2 project attracted 30,000 compounds from researchers in 26 countries. And Lilly scientist Alan Palkowitz said it’s just the first of many such collaborations.
Eli Lilly CEO Lechleiter sees 2010 pay fall 22 percent
Eli Lilly and Co. Chairman and CEO John Lechleiter received compensation valued at $12.7 million last year, down 22 percent from 2009 largely due to a change in how the drugmaker handles equity awards.
2010 compensation fell about 20 percent for top Lilly execs
Compensation for Eli Lilly and Co.’s top executives fell last year due to a change to its stock award program and as the company struggled to bring new medicines to market.
Panel OKs criminal checks on medical workers
Physicians, dentists, nurses, veterinarians, pharmacists and other medical workers would have to pay for a national criminal background check when applying for a state license under a bill pending with the Indiana Senate.
Potential competitor to Lilly drug shows promise in study
Sanofi-Aventis’s experimental diabetes drug lixisenatide, given to volunteer patients once a day, was at least as effective as Eli Lilly and Co. and Amylin Pharmaceuticals Inc.’s twice-daily medicine Byetta, a study found.
Judge’s ruling raises uncertainty for health care execs
After a federal judge in Florida struck down the entire health reform law, investors shrugged. But the uncertainty for executives in health care companies increased.
Florida judge strikes down health care overhaul
A federal judge ruled Monday that the Obama administration's health care overhaul is unconstitutional, siding with 26 states, including Indiana, that sued to block it.